1. Home
  2. SNSE vs GP Comparison

SNSE vs GP Comparison

Compare SNSE & GP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNSE
  • GP
  • Stock Information
  • Founded
  • SNSE 2005
  • GP 2010
  • Country
  • SNSE United States
  • GP Canada
  • Employees
  • SNSE N/A
  • GP N/A
  • Industry
  • SNSE Biotechnology: Pharmaceutical Preparations
  • GP Construction/Ag Equipment/Trucks
  • Sector
  • SNSE Health Care
  • GP Consumer Discretionary
  • Exchange
  • SNSE Nasdaq
  • GP Nasdaq
  • Market Cap
  • SNSE 10.8M
  • GP 12.6M
  • IPO Year
  • SNSE 2021
  • GP 2020
  • Fundamental
  • Price
  • SNSE $7.76
  • GP $0.39
  • Analyst Decision
  • SNSE Strong Buy
  • GP Strong Buy
  • Analyst Count
  • SNSE 4
  • GP 2
  • Target Price
  • SNSE $72.50
  • GP $2.33
  • AVG Volume (30 Days)
  • SNSE 25.9K
  • GP 4.0M
  • Earning Date
  • SNSE 08-05-2025
  • GP 08-13-2025
  • Dividend Yield
  • SNSE N/A
  • GP N/A
  • EPS Growth
  • SNSE N/A
  • GP N/A
  • EPS
  • SNSE N/A
  • GP N/A
  • Revenue
  • SNSE N/A
  • GP $19,847,279.00
  • Revenue This Year
  • SNSE N/A
  • GP N/A
  • Revenue Next Year
  • SNSE N/A
  • GP $52.40
  • P/E Ratio
  • SNSE N/A
  • GP N/A
  • Revenue Growth
  • SNSE N/A
  • GP N/A
  • 52 Week Low
  • SNSE $5.00
  • GP $0.28
  • 52 Week High
  • SNSE $17.40
  • GP $1.90
  • Technical
  • Relative Strength Index (RSI)
  • SNSE 52.43
  • GP 51.47
  • Support Level
  • SNSE $6.33
  • GP $0.28
  • Resistance Level
  • SNSE $10.99
  • GP $0.64
  • Average True Range (ATR)
  • SNSE 1.00
  • GP 0.06
  • MACD
  • SNSE 0.12
  • GP 0.00
  • Stochastic Oscillator
  • SNSE 41.04
  • GP 34.75

About SNSE Sensei Biotherapeutics Inc.

Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).

About GP GreenPower Motor Company Inc.

GreenPower Motor Co Inc is the manufacturer and distributor of all-electric charter, school, and city buses. The company offers electric-powered transit buses deploying electric drive and battery technologies with a lightweight chassis and low-floor body. Its product line includes all-electric transit buses, all-electric school buses, and shuttle buses. The company's buses depend on clean sheet design and utilize a custom battery management system and a proprietary flex power system for the drive motors. Geographically, the company generates a majority of its revenue from the United States of America and the rest from Canada.

Share on Social Networks: